skip to main content

Radioactive iodine may not benefit thyroid cancer patients, but they still get it

A new survey by researchers at the U-M Rogel Cancer Center and Institute for Healthcare Policy and Innovation suggests many patients are receiving the treatment when there’s no strong indication of benefit.

Fall Cancer Research Symposium

When: Monday, October 28, 2019
9am to 4pm

Where: Palmer Commons; Great Lakes Room
100 Washtenaw Avenue
Ann Arbor, MI 48109 | Maps and Directions

Register for this event using the online form

A new way of uncovering predictive biomarkers may help those with rare cancer

Large randomized clinical trials can uncover biomarkers to identify which cancer treatments are likely to work best for individual patients.

Learning to Predict Breast Cancer Metastasis

U-M Rogel Cancer Center and College of Engineering researchers found breast cancer cells that swallow up nearby stem cells, making it easier for them to invade other tissues and seed secondary tumors.

Pages